Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
Volume
30
Pagination
91 - 92
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
ISSN
0815-9319
Metadata
Show full item recordAuthors
Strasser, S; Chan, H; Ahn, S; Chuang, W; Hui, A; Tabak, F; Mehta, R; Petersen, J; Lee, C; Ma, XCollections
- Centre for Immunobiology [1013]
